Evidence map›Paper›PMID 39866856›Full record

ArticleJournal of biomedical optics2025

Quantitative assessment of the generalizability of a brain tumor Raman spectroscopy machine learning model to various tumor types including astrocytoma and oligodendroglioma.

Frédéric Leblond, Frédérick Dallaire, Katherine Ember, Alice Le Moël, Victor Blanquez-Yeste, Hugo Tavera, Guillaume Sheehy, Trang Tran, Marie-Christine Guiot, Alexander G Weil and 3 more

Abstract read
In one paragraph

Article in Journal of biomedical optics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Frédéric LeblondPolytechnique Montréal, Department of Engineering Physics, Montreal, Quebec, Canada.ORCID 0000-0002-8154-4952
Frédérick DallairePolytechnique Montréal, Department of Engineering Physics, Montreal, Quebec, Canada.
Katherine EmberPolytechnique Montréal, Department of Engineering Physics, Montreal, Quebec, Canada.ORCID 0000-0001-5454-3359
Alice Le MoëlPolytechnique Montréal, Department of Engineering Physics, Montreal, Quebec, Canada.
Victor Blanquez-YestePolytechnique Montréal, Department of Engineering Physics, Montreal, Quebec, Canada.ORCID 0009-0001-1551-7331
Hugo TaveraPolytechnique Montréal, Department of Engineering Physics, Montreal, Quebec, Canada.ORCID 0000-0002-4973-8300
Guillaume SheehyPolytechnique Montréal, Department of Engineering Physics, Montreal, Quebec, Canada.ORCID 0000-0002-4721-6066
Trang TranPolytechnique Montréal, Department of Engineering Physics, Montreal, Quebec, Canada.ORCID 0000-0002-4251-7804
Marie-Christine GuiotMontreal Neurological Institute-Hospital, Division of Neuropathology, Department of Pathology, Montreal, Quebec, Canada.
Alexander G WeilCentre hospitalier universitaire Sainte-Justine, Department of Neurosurgery, Montréal, Quebec, Canada.
Roy DudleyMcGill University Health Center, Department of Neurosurgery, Montréal, Quebec, Canada.ORCID 0000-0003-4437-0823
Costas HadjipanayisUniversity of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States.
Kevin PetreccaMcGill University, Montreal Neurological Institute-Hospital, Montreal, Quebec, Canada.

Funding

CIHR
6 · The paper itself

Abstract

Significance: Maximal safe resection of brain tumors can be performed by neurosurgeons through the use of accurate and practical guidance tools that provide real-time information during surgery. Current established adjuvant intraoperative technologies include neuronavigation guidance, intraoperative imaging (MRI and ultrasound), and 5-ALA for fluorescence-guided surgery. Aim: We have developed intraoperative Raman spectroscopy as a real-time decision support system for neurosurgical guidance in brain tumors. Using a machine learning model, trained on data from a multicenter clinical study involving 67 patients, the device achieved diagnostic accuracies of 91% for glioblastoma, 97% for brain metastases, and 96% for meningiomas. Here, the aim is to assess the generalizability of a predictive model trained with data from this study to other types of brain tumors. Approach: A method was developed to assess the generalizability of the model, quantifying performance for tumors including astrocytoma, oligodendroglioma and ependymoma, pediatric glioblastoma, and classification of glioblastoma data acquired in the presence of 5-ALA induced fluorescence. Statistical analyses were conducted to assess the impact of vibrational bands beyond contributors identified in our previous research. Results: A machine learning brain tumor detection model showed a positive predictive value (PPV) of 70% for astrocytoma, 74% for oligodendroglioma, and 100% for ependymoma. Furthermore, the PPV was 100% in classifying spectra from a pediatric glioblastoma and 90% for detecting adult glioblastoma labeled with 5-ALA-induced fluorescence. Univariate statistical analyses applied to individual vibrational bands demonstrated that the inclusion of Raman biomarkers unexploited to date had the potential to improve detectability, setting the stage for future advances. Conclusions: Developing predictive models relying on the inelastic scattering contrast from a wider pool of Raman bands may improve detection accuracy for astrocytoma and oligodendroglioma. To do so, larger tumor datasets and a higher Raman photon signal-to-noise ratio may be required.

Indexed as

AstrocytomaBrain NeoplasmsMachine LearningOligodendrogliomaSpectrum Analysis, RamanFemaleHumansMaleSurgery, Computer-Assistedbiochemistrybiomedical opticsbrain cancerfluorescenceglioblastomagliomasmachine learningneurosurgeryRaman spectroscopytissue optics

Identifiers

PMID39866856
PMCPMC11758428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.